CPhI Online

KOLINPHARMA® obtains its 5th patent in the USA for MIELSAX® !

6 Oct 2020

MILESAX® was granted because of the recognized innovation and uniqueness of the composition, with muscle relaxant and anti-inflammatory activity.

To date, Kolinpharma has obtained 4 industrial patents in Italy, 3 patents in 12 new European countries beyond Italy, 5 patents in the United States and 1 in Israel, a conquest that is a source of great pride in countries considered a worldwide reference in scientific research and of great importance in the world of nutraceuticals which testifies to the seriousness and accuracy research and confirms the ability of the R&D team to study innovative formulations and develop effective products, based on the most current scientific evidence in the various reference areas.